This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Asia
October 20-22, 2025
Westin MiyakoJapan
Book Now
Menu
Book
keyboard_arrow_right

Wednesday, October 22, 2025 – Main Conference Day 2 - JT (Japan Time, GMT+09:00)

search
Wednesday, October 22, 2025 – Main Conference Day 2 - JT (Japan Time, GMT+09:00)
search
Showing 2 of 2 Streams
08:30 - 08:35
Chairperson’s Opening Remarks: Optimizing Efficiency & Quality Control While Reducing Cost of Manufacturing
08:35 - 09:05
Accelerating Process Development and Reducing Manufacturing Cost for Biologics: A Case Study
09:05 - 09:35
Streamline Biologics Process Characterization and Control Strategy Development
  • Sadettin Ozturk, Ph.D. - Chief Technology Officer, STRM.BIO
09:35 - 10:05
Optimizing Process Development and Clinical Production Efficiency with Continuous Improvement Projects
08:30 - 08:35
Chairperson’s Welcome and Opening Remarks: Global Regulatory Alignment and Harmonization
08:35 - 09:05
Early Development of a Global Regulatory Strategy
  • Jack Wong - CEO and Founder, Asia Regulatory Professionals Association (ARPA)
09:05 - 09:35
Strategies for Meeting U.S. FDA Cell Therapy IND Requirements: A Case Study Approach
  • Minghua Liu - CMC Consultant, Regulatory Affairs, Eliquent Life Sciences
09:35 - 10:05
How Startups and Researchers Can Collaborate with Government and Support Organizations
  • Maggie Lo - Senior VP, Life and Health Technology, Office for Attracting Strategic Enterprises
10:05 - 10:45
Networking Refreshment Break in Poster/Exhibit Hall
Showing 2 of 2 Streams
10:45 - 11:15
Leveraging AI And Advanced Analytics to Enhance Bioprocess Efficiency
11:15 - 11:45
AI-Driven Bioprocessing: Innovations in Upstream and Downstream Development
  • Mark Duerkop - Chief Executive Officer, Novasign, Austria
11:45 - 12:15
The Future of Biopharma: AI-Enabled Automation and Continuous Processing for Faster, Smarter Production
  • Mrinal Bachute - Head Industry Connect, Associate Professor, Symbiosis Institute of Technology, Symbiosis International University
12:15 - 12:45
Scientific Track Presentation
10:45 - 11:15
Navigating China’s Evolving Regulatory Landscape and Bridging it with Global Development
  • Wendy Yan - MBA, former SVP & Global Head of Regulatory Affairs, BeiGene
11:15 - 11:45
Ensuring Quality and Safety for Cell & Gene Therapy Products Under Evolving Guidelines
11:45 - 12:15
Global Regulatory Strategy, Policy Harmonization, and Bridging Japan’s Requirements with Global Development Programs
12:15 - 12:45
Scientific Track Presentation
12:45 - 13:55
Luncheon in the Poster/Exhibit Hall
Showing 2 of 2 Streams
13:55 - 14:00
Chairperson’s Remarks: Achievements in Intensified, Continuous, and Sustainable Bioprocessing
14:00 - 14:30
Enabling Robust Continuous Biomanufacturing Using Digital Twins
  • Christoph Herwig - Founder, Lisalis GmbH
14:30 - 15:00
Sustainability Considerations in Regards to Geographical and Process Intensification
  • Yuki Abe, Ph.D., - Director, BioPharm Services Ltd.
15:00 - 15:30
Scientific Track Presentation
13:55 - 14:00
Chairperson’s Remarks: Regulatory & CMC Strategies for Emerging Modalities
14:00 - 14:30
Future Direction on CMC of Next Generation ADCs
  • Gang Qin, PhD - President, GeneQuantum Healthcare (Suzhou) Co., Ltd.
14:30 - 15:00
Implementing Continuous Processing for Novel Modalities from Small to Large Scale – Overcoming Current and Planning for Future Challenges
  • Scott Wheelwright, PhD - Co-Founder and President, BEI
15:00 - 15:30
Scientific Track Presentation
15:30 - 16:00
Networking Refreshment Break in Poster/Exhibit Hall
Showing 2 of 2 Streams
16:00 - 16:30
Establishing Flexible, Fully Disposable GMP Facility
16:30 - 17:00
Designing High Productivity, Cost Effective Modular Bioprocessing Facilities – Successes and Lessons Learned
17:00 - 17:30
Global Strategies for Operating in an Evolving Landscape – Next Generation Bioprocessing, Digitalisation and Facilities of the Future
  • Daisuke Kajihara - Senior Director of Bioprocess Technology Research Laboratories, Daiichi Sankyo Co., Ltd., Japan
16:00 - 16:30
Process Automation with AI Technology for Cell Therapies
  • Yasuhiro Takagi - Senior Director, Astellas Pharma Inc., Japan
16:30 - 17:00
Utilizing Semi-Automated, Intensified Processes for Allogeneic Cell Therapies
17:00 - 17:30
Benefits and Challenges of Adopting Novel Platforms to Intensify Processes and Ensure Quality in Next-Generation Biologics Manufacturing
17:30 - 17:35
Close of BPI Asia 2025
Tuesday, October 21, 2025 – Main Conference Day 1
Choose Day